GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Peijia Medical Ltd (HKSE:09996) » Definitions » Enterprise Value

Peijia Medical (HKSE:09996) Enterprise Value : HK$1,677.0 Mil (As of May. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Peijia Medical Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Peijia Medical's Enterprise Value is HK$1,677.0 Mil. Peijia Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-428.0 Mil. Therefore, Peijia Medical's EV-to-EBIT ratio for today is -3.92.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Peijia Medical's Enterprise Value is HK$1,677.0 Mil. Peijia Medical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-428.0 Mil. Therefore, Peijia Medical's EV-to-EBITDA ratio for today is -3.92.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Peijia Medical's Enterprise Value is HK$1,677.0 Mil. Peijia Medical's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was HK$482.5 Mil. Therefore, Peijia Medical's EV-to-Revenue ratio for today is 3.48.


Peijia Medical Enterprise Value Historical Data

The historical data trend for Peijia Medical's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peijia Medical Enterprise Value Chart

Peijia Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial - 14,814.68 6,064.86 4,629.06 4,230.33

Peijia Medical Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 6,064.86 3,081.96 4,629.06 3,193.34 4,244.09

Competitive Comparison of Peijia Medical's Enterprise Value

For the Medical Devices subindustry, Peijia Medical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peijia Medical's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Peijia Medical's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Peijia Medical's Enterprise Value falls into.



Peijia Medical Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Peijia Medical's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as

Peijia Medical's Enterprise Value for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Peijia Medical  (HKSE:09996) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Peijia Medical's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1677.005/-428.021
=-3.92

Peijia Medical's current Enterprise Value is HK$1,677.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Peijia Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-428.0 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Peijia Medical's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1677.005/-428.021
=-3.92

Peijia Medical's current Enterprise Value is HK$1,677.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Peijia Medical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-428.0 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Peijia Medical's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1677.005/482.495
=3.48

Peijia Medical's current Enterprise Value is HK$1,677.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Peijia Medical's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was HK$482.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Peijia Medical Enterprise Value Related Terms

Thank you for viewing the detailed overview of Peijia Medical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Peijia Medical (HKSE:09996) Business Description

Traded in Other Exchanges
N/A
Address
8 Zhongtian Street, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN
Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.
Executives
Jinnius Drive Trust 2103 Interests held jointly with another person
Xinyue International Limited 2103 Interests held jointly with another person
Ye Hong 2103 Interests held jointly with another person
Zhang Ping Ye 2103 Interests held jointly with another person
Zhang Yi 2301 Trustee
Hanlindale Trust 2103 Interests held jointly with another person
Hillhouse Investment Management, Ltd. 2102 Investment manager
Hh Imv Holdings, L.p. 2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p. 2201 Interest of corporation controlled by you
Hh Sum-xxiv Holdings Limited 2101 Beneficial owner
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Shi Yi 2201 Interest of corporation controlled by you

Peijia Medical (HKSE:09996) Headlines

No Headlines